Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir

AIDS. 2017 Jan 28;31(3):455-457. doi: 10.1097/QAD.0000000000001351.

¹ aUnit of Infectious Diseases, A. Manzoni Hospital, Lecco bUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Sassari, Sassari cUnit of Infectious Diseases, San Matteo Hospital, Pavia dInfectious Diseases Clinic, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza eDepartment of Infectious Diseases, Amedeo di Savoia Hospital, Turin fUnit of Infectious Diseases, ASST Valle Olona, Busto Arsizio gInfectious Diseases Unit, DIBIC 'Luigi Sacco', University of Milan, Milan hUnit of Infectious Diseases, Garibaldi Hospital, Catania iUnit of Infectious Diseases, University of Bari, Bari jDepartment of Infectious Diseases, ASST Fatebenefratelli-Sacco, Milan, Italy.

No abstract available

Publication types